Today: 19 May 2026
Browse Category

NASDAQ:ERAS 14 January 2026 - 6 March 2026

Tango Therapeutics stock jumps 36% after Q4 results, Erasca cancer trial pact

Tango Therapeutics stock jumps 36% after Q4 results, Erasca cancer trial pact

Tango Therapeutics shares rose 36% after announcing a collaboration with Erasca to test vopimetostat in pancreatic and lung cancers. The company reported a fourth-quarter net loss of $38.7 million and cash reserves of $343.1 million. Tango plans to start a pivotal pancreatic cancer trial in 2026 and released early efficacy data from ongoing studies.
6 March 2026
···

Stock Market Today

  • Nifty 50 Index Faces Pressure Amid Rising Indian Bond Yields and Rupee Decline
    May 19, 2026, 12:21 AM EDT. The Nifty 50 Index fell to ₹23,650, down 10% from this year's peak, amid economic concerns stemming from the US-Iran war and India's reliance on Gulf oil. Inflation rose to 3.48% in April, the fastest in over a year, raising expectations of Reserve Bank of India (RBI) interest rate hikes. Indian bond yields surged, with 10-year yields climbing to 7.13%, the highest since May 2024, raising borrowing costs for companies. Concurrently, the Indian rupee weakened significantly, with USD/INR reaching a record 96.35, reducing foreign investor attractiveness. Technical analysis shows a bearish double-top pattern on the Nifty 50, suggesting potential further declines toward ₹23,000 support.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Go toTop